190 related articles for article (PubMed ID: 21118508)
21. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
22. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
[TBL] [Abstract][Full Text] [Related]
23. Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.
Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Inoue K; Tabei T
Breast; 2009 Aug; 18(4):238-43. PubMed ID: 19625190
[TBL] [Abstract][Full Text] [Related]
24. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
[TBL] [Abstract][Full Text] [Related]
25. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
Wapnir IL; Anderson SJ; Mamounas EP; Geyer CE; Jeong JH; Tan-Chiu E; Fisher B; Wolmark N
J Clin Oncol; 2006 May; 24(13):2028-37. PubMed ID: 16648502
[TBL] [Abstract][Full Text] [Related]
26. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
27. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.
Dalberg K; Mattsson A; Sandelin K; Rutqvist LE
Breast Cancer Res Treat; 1998 May; 49(1):69-78. PubMed ID: 9694613
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.
Gosset M; Hamy AS; Mallon P; Delomenie M; Mouttet D; Pierga JY; Lae M; Fourquet A; Rouzier R; Reyal F; Feron JG
PLoS One; 2016; 11(8):e0159888. PubMed ID: 27494111
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
30. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
31. Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.
Ishitobi M; Fukui R; Hashimoto Y; Kittaka N; Nakayama T; Tamaki Y
Anticancer Res; 2017 Sep; 37(9):5293-5299. PubMed ID: 28870967
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of ipsilateral breast tumor recurrence.
Kolben T; Schwarz TM; Goess C; Blume C; Degenhardt T; Engel J; Wuerstlein R; Ditsch N; Harbeck N; Kahlert S
Int J Surg; 2015 Nov; 23(Pt A):141-6. PubMed ID: 26449651
[TBL] [Abstract][Full Text] [Related]
33. Investigation of factors related to periods to ipsilateral breast tumor recurrence after breast-conserving surgery and measures for preventing recurrence in early breast cancer.
Nishimura R; Akizuki M; Tashima R; Ootao R
Breast Cancer; 2006; 13(2):152-8. PubMed ID: 16755110
[TBL] [Abstract][Full Text] [Related]
34. When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
Gentilini O; Botteri E; Rotmensz N; Santillo B; Peradze N; Saihum RC; Intra M; Luini A; Galimberti V; Goldhirsch A; Veronesi U
Ann Oncol; 2007 Mar; 18(3):468-72. PubMed ID: 17158776
[TBL] [Abstract][Full Text] [Related]
35. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
[TBL] [Abstract][Full Text] [Related]
36. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence.
Dalberg K; Liedberg A; Johansson U; Rutqvist LE
Eur J Surg Oncol; 2003 Mar; 29(2):143-54. PubMed ID: 12633557
[TBL] [Abstract][Full Text] [Related]
37. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N
Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet Oncol; 2018 Jan; 19(1):27-39. PubMed ID: 29242041
[TBL] [Abstract][Full Text] [Related]
39. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.
Whelan T; Clark R; Roberts R; Levine M; Foster G
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):11-6. PubMed ID: 8083103
[TBL] [Abstract][Full Text] [Related]
40. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
